Clinical trial Recruiting at 2 sites Interventional Ages 18 to 85

Electro-acupuncture's effect on lowering blood pressure

Official title: Neural Mechanism of the Effect of Acupuncture on Hypertension

Run by University of California, Irvine · NCT00932139 · Data updated 2026-11-12

This study is testing whether electro-acupuncture can help lower blood pressure in people with mild to moderate hypertension, especially looking at how it works for different genders.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment160 (estimated)
SponsorUniversity of California, Irvine
Academic / other
Locations2 sites (Irvine, California and 1 other locations)
StatusRecruiting
StartedFebruary 2003
Main results expectedSeptember 2027
Study endsDecember 2027
Registry record updatedApril 15, 2025
Trial IDNCT00932139 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with mild coronary disease and high blood pressure, with or without antihypertensive medication.

Probably not a fit

Patients with severe coronary disease, significant ECG abnormalities, or other serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of electro-acupuncture (EA) on reducing blood pressure in patients with mild to moderate hypertension. It aims to demonstrate that EA can decrease hypertensive responses both at rest and under stress, while also exploring the underlying mechanisms involved. The research will assess how EA affects sympathetic nervous system activity and its potential therapeutic benefits for hypertensive patients, with a focus on gender differences in response. Participants will receive either a control or test EA intervention to evaluate these effects.

Why it matters

Potential benefit: If successful, this approach could provide a non-pharmacological treatment option for managing hypertension.

How similar studies have gone: Previous studies have shown promising results for electro-acupuncture in managing hypertension, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with mild coronary disease, and no significant ECG change reflecting ischemia at rest.
* Patients with high blood pressure with or without antihypertensive medication.

Exclusion Criteria:

* Pregnant or nursing women
* Individuals with severe coronary disease (continuous angina)
* Conduction abnormalities on ECG consistent with left bundle branch block
* Cardiac arrhythmias associated with low blood pressure (90 mmHg)
* Peripheral vascular disease
* Orthopedic disease
* Diabetic or psychological illness that could interfere with safe performance of exercise of psychophysiological stress testing
* Those with known sensitivity to topical preparations or strong reactions to medical dressings and skin tapes

Where it's running

  • Susan Samueli Integrative Health Institute
    Irvine, California, United States
    Recruiting
  • UCIMedical Center
    Orange, California, United States
    Recruiting

Study contacts

  • Principal investigator: Shaista Malik, MD, PhD, MPH — University of California, Irvine
  • Study coordinator: Stephanie Tjen-A-Looi, PhD
  • Email: stjenalo@uci.edu
  • Phone: 9494005909

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.